The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Pneumocystis jirovecii pneumonia in kidney transplantation
Abstract
Pneumocystis jirovecii pneumonia (PCP) remains an important cause of morbidity and mortality in immunocompromised renal transplant recipients. In recent years, PCP outbreaks in renal transplant centers have been reported in many countries. Person-to-person transmission between PCP patients and other recipients lacking prophylaxis is one of the possible sources of infection. To prevent infection, effective prophylaxis in susceptible patients is recommended. Trimethoprim-sulfamethoxazole (TMP-SMX) is the most effective drug for PCP prophylaxis, but its recommended duration of use after transplantation varies among the different guidelines. The European Renal Association recommends a prophylaxis period of 4 months after transplantation, the American Society of Transplantation (AST) 6-12 months, and the Kidney Disease Improving Global Outcomes guidelines 3-6 months. Lifelong prophylaxis with TMP-SMX is not recommended in renal transplant recipients; however, in many cases, PCP has occurred after the recommended prophylaxis periods after transplantation. In this minireview, we discuss the risk factors including environmental-nosocomial exposure; state-of-the-art diagnosis, treatment, prophylaxis and isolation; and references to the AST 2009 guidelines with the aim of integrating our experience with PCP outbreaks into recent reports, and we discuss how renal transplant recipients can be protected from PCP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“transplant recipients are routinely prescribed cotrimoxazole prophylaxis to prevent infections caused by Pneumocystis jirovecii (PCP) [22,24].”
From Pharmacometabolomics Study of Sulfamethoxazole and Trimethoprim in Kidney Transplant Recipients: Real-World Metabolism and Urinary Excretion (2025) · cites this paper as [24]
Citations
Cites
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Infection in Solid-Organ Transplant Recipients
Fishman, J. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064928 · Cited by 1,950
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Kasiske, B. L., Zeier, M. G., Chapman, J. R., Craig, J. C., Ekberg, H., Garvey, C. A., Green, M. D., Jha, V., Josephson, M. A., Kiberd, B. A., et al. (2010) · Kidney International · doi:10.1038/ki.2009.377 · Cited by 1,735
Kaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H. (2009) · PsycEXTRA Dataset · doi:10.1037/e537722009-001 · Cited by 1,343
Thomas, C. F., & Limper, A. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032588 · Cited by 1,037
The KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Josephson, M. A. (2013) · Cited by 898
KOVACS, J. A., HIEMENZ, J. W., MACHER, A. M., STOVER, D., MURRAY, H. W., SHELHAMER, J., LANE, H. C., URMACHER, C., HONIG, C., LONGO, D. L., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-663 · Cited by 855
Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the Fungi
Edman, J. C., Kovacs, J. A., Masur, H., Santi, D. V., Elwood, H. J., & Sogin, M. L. (1988) · Nature · doi:10.1038/334519a0 · Cited by 789
Yale, S. H., & Limper, A. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.1.5 · Cited by 644
Masur, P. B. H., Kaplan, J. E., & Holmes, K. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00002 · Cited by 567
Cited by
Tasaka, S., & Tokuda, H. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0453-0 · Cited by 123
Hof, M. A. J., de Haan, H., Stepanovic, S., Bakker, S. J. L., Hak, E., Hopfgartner, G., Klont, F., & Investigators, T. (2025) · Metabolites · doi:10.3390/metabo15070473 · Cited by 1
“The latter, drug-induced immunosuppression, is particularly prevalent in kidney transplantation, where transplant recipients are routinely prescribed cotrimoxazole prophylaxis to prevent infections caused by Pneumocystis jirovecii (PCP) [22,24].”
Metadata
- Authors
- Goto, N., & Oka, S.
- Affiliations
- Japanese Red Cross Nagoya Daini Hospital (JP)
- National Center for Global Health and Medicine (JP)
- Corresponding author
- Goto, N.
- Venue
- Transplant Infectious Disease
- Publisher
- Wiley
- Published
- 2011-10-31
- Volume
- 13
- Issue
- 6
- Pages
- 551-558
- ISSN
- 1398-2273 (ISSN-L)
- 1399-3062
- OpenAlex
- W2090391796
- Cited by
- 74
- References
- 68
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 6 · 2019: 10 · 2018: 4 · 2017: 7 · 2016: 10 · 2015: 5 · 2014: 11 · 2013: 3 · 2012: 5
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplant Infectious Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Keywords
- Pneumocystis carinii pneumonia, kidney transplantation, immunocompromised transplant recipients, nosocomial transmission, trimethoprim-sulfamethoxazole prophylaxis, prophylaxis duration, risk factors, diagnosis, isolation, infection control
- MeSH terms
- Anti-Bacterial Agents, Cross Infection, Humans, Pneumonia, Pneumocystis, Postoperative Complications, Trimethoprim, Sulfamethoxazole Drug Combination, Kidney Transplantation, Immunocompromised Host, Antibiotic Prophylaxis, Pneumocystis carinii
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pneumocystis jirovecii pneumonia in kidney transplantation. https://app.cochat.ai/papers/10.1111/j.1399-3062.2011.00691.x
- The paper
- Goto, N., & Oka, S. (2011). Pneumocystis jirovecii pneumonia in kidney transplantation. Transplant Infectious Disease. https://doi.org/10.1111/j.1399-3062.2011.00691.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
